Helixmith Co., Ltd (KOSDAQ:084990)
South Korea · Delayed Price · Currency is KRW 6,220.00
+100.00 (1.63%)
Dec 30, 2025, 3:30 PM KST
Helixmith Market Cap
Helixmith has a market cap or net worth of 286.41 billion as of December 30, 2025. Its market cap has increased by 105.28% in one year.
Market Cap
286.41B
Enterprise Value
204.09B
Revenue
3.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,220.00
Market Cap Chart
Since December 29, 2005, Helixmith's market cap has increased from 238.64B to 286.41B, an increase of 20.02%. That is a compound annual growth rate of 0.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 29, 2025 | 281.81B | 126.67% |
| Dec 30, 2024 | 124.33B | -51.50% |
| Dec 28, 2023 | 256.37B | -35.45% |
| Dec 29, 2022 | 397.14B | -53.54% |
| Dec 30, 2021 | 854.88B | -3.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |